Moreover, dependence of CD44 on versican, a large HA-binding proteoglycan, has been shown in ovarian cancer where HA and versican form a pericellular matrix around CD44-expressing ovarian cancer cells that further promotes their motility and invasion in vitro [71]. Here, CD44 is linked to ovarian cancer.